ORIX (IX) is a Financial Services company in the Financial Conglomerates industry. It has a market capitalization of $37.30B. Over the most recent reported fiscal year, revenue grew 18.6%. Nama's AI scorecard rates it Buy, 5.8 out of 10. On 12-month momentum it ranks in the leading band of its market.
AI scorecard
Buy · 5.8/10
Positive, at the low end of Buy. As of Nov 7, 2026.
Momentum
Leading · +47.1% over 12 months ex. last
Top 20% of its market on the past year's steady rise.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-66.5%
How far the last close sits under the highest price of the past five years.
Market cap
$37.30B
Trailing P/E
—
Price / book
1.3
Price / sales
1.7
FCF yield
—
Dividend yield
2.8%
Gross margin
43.6%
Operating margin
21.5%
Net margin
17.9%
Revenue growth (YoY)
+18.6%
Revenue growth (3-yr annual)
+10.0%
EPS growth (YoY)
—
FCF/share growth (YoY)
—
Beta
0.7
Exchange
NYSE
Sector
Financial Services
Industry
Financial Conglomerates
IX earnings
Beat the EPS estimate in 2 of 3 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q4 2025
May 12, 2025
$2.42
$0.66
+266.7%
$2.81B
Q3 2025
Feb 10, 2025
$0.51
$0.53
-3.8%
—
Q2 2025
Nov 8, 2024
$0.55
$0.50
+10.0%
—
IX analyst price target
Median target $41.09 from 1 analysts, ranging $41.09 – $41.09.
Nama's AI scorecard currently rates ORIX Buy (5.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is the IX price target?
The median analyst price target from 1 analysts is $41.09, with a range of $41.09 – $41.09.
Is IX Shariah compliant?
Nama's AAOIFI-style screen reads ORIX as Not Shariah Compliant. At least one of the three ratios or the industry test failed.